Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02702180
Brief Title: Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA)

First Submitted : February 28, 2016
First Submitted that Met QC Criteria : March 2, 2016
First Posted : March 8, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 23, 2019
Last Update Posted : December 24, 2019